Primer on Percutaneous Ablation of Benign Liver Tumors
Shane A. Wells, Timothy J. Ziemlewicz, Meghan G. Lubner – 2 October 2018
Shane A. Wells, Timothy J. Ziemlewicz, Meghan G. Lubner – 2 October 2018
Sarah T. K. Sin, Yan Li, Ming Liu, Yun‐Fei Yuan, Stephanie Ma, Xin‐Yuan Guan – 2 October 2018 – Hepatocellular carcinoma (HCC) is one of the most common and lethal cancer types worldwide, especially in Asian countries. Genetic alterations, including hyperactivation of oncogenes and loss of expression of tumor suppressor genes, greatly contribute to the initiation and progression of HCC. Here we report that down‐regulation of trophoblast cell surface antigen 2 (TROP‐2) was frequently detected in HCC.
Miguel H. Malespin – 2 October 2018
Uyen Kim To, Guadalupe Garcia‐Tsao – 2 October 2018
Kevin M. Rank, John Lake – 2 October 2018
Jemma Mildon, Johann Willers, Sam J. Thomson – 2 October 2018
Uyen Kim To, Guadalupe Garcia‐Tsao – 2 October 2018
Kevin M. Rank, John Lake – 2 October 2018
Luz Helena Gutierrez Sanchez, Kyoko Tomita, Qianqian Guo, Kunimaro Furuta, Husam Alhuwaish, Petra Hirsova, Saurabh Baheti, Bonnie Alver, Ryan Hlady, Keith D. Robertson, Samar H. Ibrahim – 1 October 2018 – With the epidemic of obesity, nonalcoholic fatty liver disease (NAFLD) has become the most common pediatric liver disease. The influence of a perinatal obesity‐inducing diet (OID) on the development and progression of NAFLD in offspring is important but incompletely studied.